China's Andon Health to supply at-home COVID-19 tests to U.S.

BEIJING, Jan 14 (Reuters) - China's Andon Health Co Ltd (002432.SZ) said on Friday it has signed a contract worth $1.28 billion with the U.S. Army Contracting Command to supply COVID-19 self-test kits.

Andon Health's unit iHealth Labs Inc has agreed to provide at-home coronavirus antigen test kits that can serve 250 million people, the company said in a stock exchange filing.

The U.S. Army Contracting Command signed the contract on behalf of the country's Department of Health and Human Services, Andon Health said.

Earlier in the week, iHealth Labs signed a contract worth $ 120 million with the New York State Department of Health to supply the self-test kits. It had also received orders totalling $65.3 million sent from the New York State Department of Health in December, Andon Health said late on Wednesday.

Andon said iHealth Labs also obtained contracts for the kits worth a combined $148.3 million from The Commonwealth of Massachusetts and Executive office of Health and Human Services between Dec. 3, 2021 and Jan. 5, 2022.

Reporting by Roxanne Liu and Meg Shen; Editing by Richard Pullin

Our Standards: The Thomson Reuters Trust Principles.